Loss of a tumor-suppressor gene function appears to play a critical role in the multistep process of neoplastic transformation of Syrian hamster embyro (SHE) cells in vitro. Clonal variants of two independent, preneoplastic cell lines have been isolated that have either retained (termed supB +) or lost (termed supB W) the ability to suppress the tumorigenicity of a highly malignant benzo[a]pyrene-transformed SHE cell line (BP6T) in cell hybrids. We have pursued several approaches in an attempt to identify genes that are responsible for tumor suppression in these cells. The only consistent differences detected in twodimensional gel analyses of supB+ and supB-cellular proteins were decreases in the levels of two high molecular weight isoforms of tropomyosin in supB cells. Differential screening of a supB+ cDNA library for genes that are preferentially expressed in supB+ cells yielded cDNA clones for four genes, i.e., collagen type II, collagen type IX, H19, and a previously unidentified gene (clone 5). Nuclear run-on assays suggested that higher transcription rates were responsible for the increased steady-state levels of some of these transcripts in supB+ cells. DNA sequence comparisons showed that two copies of a 9 bp element, previously identified in each of the mouse H19 enhancers, were also present in the 5' flanking region of the rat type II collagen gene. A transcription factor that controls expression of the collagen and H19 genes through binding to this conserved motif would be an attractive candidate for the supB + gene or at least a mediator of the supB+ phenotype.
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Role of Tumor-Suppressor Genes in Multistep Carcinogenesis
It is now well established that the carcinogenic process requires the accumulation of multiple heritable alterations for the complete malignant transformation of normal cells (1) (2) (3) . It is also clear that the inactivation of tumor-suppressor genes plays an important role in the genesis of a wide variety of human tumors (3, 4) . Strong evidence for this concept has been provided by studies of the suppression of tumorigenicity in somatic cell hybrids (5, 6) , genetic predispositions to cancer (7, 8) , and nonrandom chromosomal deletions or allelic losses in specific chromosomal regions (9, 10) . A number of these tumor-suppressor genes have recently been isolated by molecular cloning techniques (11) (12) (13) (14) (15) , and in several cases tumor-suppressor activity has been demonstrated in functional assays (16) (17) (18) We have previously demonstrated that the loss or inactivation of a tumor-suppressor gene function is a critical event during the neoplastic transformation of carcinogen-treated or oncogene-transfected Syrian hamster embryo cells in vitro (19, 20) . The conversion of these normal cells to fully malignant tumor cells is clearly a multistep process (Fig. 1) . Rare cells in carcinogen-treated cultures escape cellular senescence and form immortal (sen-) cell lines (21, 22 (23) . These subclones are designated supB+ or supB -since BP6T cells represent only one of at least three different complementation groups for tumor suppression of hamster sarcomas (24) . Interestingly, the supB -phenotype co-segregates with the ability to reversibly grow with high cloning efficiencies in soft agar supplemented with tumor cell-conditioned media or a combination of epidermal growth factor, insulin, and platelet-derived growth factor (19, 23) .
Identification of Genes Preferentially Expressed in Cells Retaining the Ability to Suppress Tumorigenicity
To isolate candidates for the BP6T tumor-suppressor gene function, we have used two approaches to identify genes that are preferentially expressed in supB+ cells relative to supB -cells. The feasibility of these approaches is enhanced by the fact that the supB+ and supB -cell lines are very closely related, having been subcloned from the same parental lines. In addition, we have used supB + and supB -variants derived from two independent parental cell lines, i.e., DES4 and lOW (23) ; this should increase the probability that the alterations bThe ratio of hybrid colonies formed with BP6T cells that grow in agar to total hybrid colonies forned on plastic.
cl/tumor suppression ratio. These data were modified from Koi et al. (23) with permission.
we have detected are directly related to the supB+ phenotype rather than simply fortuitous events.
Initially, we examined the levels of more than 1000 [35S]methionine-labeled proteins from total cell lysates of the supB + and supB -subclones using the Quest system (25) for quantitative two-dimensional gel electrophoresis. These studies were performed in collaboration with Michael Lambert and James Garrels (Cold Spring Harbor Laboratory). Given the sensitivity of this type of analysis, specific protein levels were very similar between the two cell types, as expected for these clonal derivatives. The only consistent alterations that were detected between each ofthe supB + and supB -cell lines were reductions of two high molecular weight tropomyosins in supB -cells (26) . These tropomyosin isoforms were identified by comparisons with two-dimensional gel patterns of rat and human proteins as well as by immunoprecipitation with tropomyosin-specific antisera. Tropomyosin 1 and tropomyosin 2 levels were decreased 6-fold and 2-fold, respectively, in supB -cells relative to supB+ cells. Analysis of silver-stained gels revealed similar reductions in the steady-state levels of these proteins in supB -cells. Likewise, comparable decreases in tropomyosin 1 mRNA were observed by Northern analysis with a rat tropomyosin cDNA probe in supB -cells.
Previous studies by several laboratories have reported decreased expression of high molecular weight tropomyosin isoforms in virally and chemically induced tumor cells relative to immortal precursor cells (27) (28) (29) (30) Northern analysis with the remaining cDNA (clone 5) revealed a series of transcripts, with major species of 2.5 kb and 3.0 kb as well as several less abundant, larger mRNAs. These transcripts were observed in each of the supB + lines and normal SHE cells but were undetectable in the supB-lines and BP6T cells. DNA sequence analysis of over 2 kb at the 3' end ofthis cDNA has failed to reveal any significant similarities with sequences currently in the GenBank or European Molecular Biology Laboratory databases.
In an attempt to understand the basis for the coordinate expression of these genes in supB+ and supBcells, nuclear run-on assays were performed for the collagen and H19 genes. These studies suggested that higher transcription rates were responsible for the increased steady-state levels of these transcripts in supB+ cells. DNA sequence comparisons showed that a 9 bp element, TGT(T/C)TGCAG, that was previously identified in each of the mouse H19 enhancers was also present twice in the 5' flanking region of the rat type II collagen gene (36, 40) . Preliminary gel retardation assays revealed the presence of factor(s) in nuclear extracts of supB+ cells that bound to an oligonucleotide containing this conserved motif. Current studies using cDNA expression vector libraries are directed at the isolation of factors that bind to oligonucleotides containing this sequence element.
Conclusions
In this review, we have described two approaches that are directed toward the isolation of the supB+ tumor-suppressor gene. Although the identity of this gene is still unknown, a series of genes whose expression is coordinately regulated with the supB + phenotype have been identified. If techniques such as differential cDNA screening and two-dimensional protein gel analysis are to succeed, it is essential that the cells being compared are as closely related as possible. The supB + and supBcells that we have studied appear to fulfill this criteria. Furthermore, these techniques are based on the hypothesis that the expression of the supB+ tumor-suppressor gene will be absent or greatly decreased in supB-cells. While this assumption is valid for several tumor-suppressor genes that have previously been cloned (11, 12) , genes like the P53 gene, which is functionally inactivated by point mutations (41), would be missed by these techniques.
The detection of a tumor-suppressor gene product by quantitative two-dimensional gel analysis is limited to moderately abundant proteins that are clearly resolved under the electrophoresis conditions employed. Likewise, isolation of the supB+ gene by differential cDNA screening requires that this gene be expressed as a relatively abundant transcript (> 0.05% of the total mRNA) so that it is represented at a sufficient level in the 32P-labeled probe to yield a detectable hybridization signal (42) . However, subtractive hybridization techniques have been used to isolate considerably less abundant transcripts (43, 44) , and they provide an attractive extension of the differential cDNA screening studies described in this report. Therefore, our current efforts are directed at the construction of a supB+ cDNA library after several rounds of subtraction with supBmRNA. Subtractive hybridization techniques using a mammalian expression vector may also be useful as an enrichment for supB + cDNAs with the potential to suppress the tumorigenicity of BP6T cells. Such a subtracted supB+ library could be used in gene transfer assays like those described by Noda and co-workers (16) to screen for cDNAs with tumor-suppressing activity.
Of the genes identified whose expression is coordinately regulated with a tumor-suppressor function for BP6T cells 
